0,911  0,005  Apoptosis agonist
0,904  0,003  Chemopreventive
0,898  0,004  Antihypercholesterolemic
0,896  0,003  Cholesterol antagonist
0,895  0,005  Antiinflammatory
0,866  0,009  Transcription factor NF kappa B inhibitor
0,789  0,009  Antineoplastic (lung cancer)
0,781  0,004  Hepatic disorders treatment
0,774  0,007  Antileukemic
0,766  0,001  Antifungal enhancer
0,764  0,013  Antineoplastic (breast cancer)
0,744  0,003  Antiviral (Herpes)
0,738  0,005  Nitric oxide antagonist
0,740  0,009  Alzheimer's disease treatment
0,739  0,019  Caspase 9 stimulant
0,713  0,007  Bone diseases treatment
0,708  0,004  Apoptosis antagonist
0,702  0,010  Chemoprotective
0,684  0,007  Antineoplastic (melanoma)
0,682  0,015  TNF expression inhibitor
0,648  0,008  Lipoprotein disorders treatment
0,647  0,007  Antineoplastic (pancreatic cancer)
0,649  0,020  Cyclophilin D inhibitor
0,649  0,020  Antidiabetic
0,626  0,007  Antineoplastic (glioma)
0,622  0,009  NOS3 expression inhibitor
0,608  0,005  Antihypoxic
0,597  0,005  Hepatoprotectant
0,609  0,017  Prostate cancer treatment
0,595  0,005  Hair growth stimulant
0,577  0,013  AR expression inhibitor
0,575  0,013  Antiosteoporotic
0,573  0,018  Antineoplastic (ovarian cancer)
0,556  0,013  Antifungal
0,554  0,015  Cardioprotectant
0,550  0,012  Antiprotozoal (Leishmania)
0,535  0,002  Cholesterol synthesis inhibitor
0,551  0,019  Antipruritic, allergic
0,539  0,009  Antineoplastic (glioblastoma multiforme)
0,556  0,028  Antineoplastic (colorectal cancer)
0,531  0,010  Hypolipemic
0,515  0,003  Sodium/bile acid cotransporter inhibitor
0,539  0,028  Antineoplastic (colon cancer)
0,530  0,025  Immunosuppressant
0,526  0,021  Cytotoxic
0,520  0,018  Antioxidant
0,509  0,018  NOS2 expression inhibitor
0,488  0,004  Antiinfertility, female
0,487  0,004  DNA polymerase I inhibitor
0,480  0,006  UGT2B7 substrate
0,482  0,010  Wound healing agent
0,492  0,026  CYP2C19 inhibitor
0,475  0,021  Metabolic disease treatment
0,465  0,013  Antineoplastic (liver cancer)
0,476  0,024  Antipsoriatic
0,461  0,012  UGT1A1 substrate
0,467  0,018  Hypoglycemic
0,465  0,017  UGT2B4 substrate
0,446  0,005  Insulin sensitizer
0,458  0,026  Antineoplastic (brain cancer)
0,476  0,048  Antibacterial
0,433  0,006  Lipocortins synthesis antagonist
0,447  0,021  Hypoxia-inducible factor 1 alpha inhibitor
0,435  0,010  Contraceptive
0,438  0,017  Antineoplastic (renal cancer)
0,434  0,017  Antineoplastic (endocrine cancer)
0,445  0,031  Caspase 3 stimulant
0,437  0,024  Proliferative diseases treatment
0,436  0,029  Carcinogenic
0,409  0,010  Antiacne
0,445  0,047  Atherosclerosis treatment
0,446  0,051  Antiobesity
0,393  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,404  0,015  UGT1A4 substrate
0,397  0,011  Antiviral (Influenza)
0,434  0,056  Antiprotozoal
0,387  0,018  Abortion inducer
0,366  0,005  UGT2B9 substrate
0,371  0,009  Liver fibrosis treatment
0,372  0,015  Platelet adhesion inhibitor
0,366  0,009  Antiviral (Influenza A)
0,368  0,013  Prostate disorders treatment
0,375  0,023  Antineoplastic enhancer
0,361  0,014  Antipruritic, non-allergic
0,359  0,013  Interferon gamma antagonist
0,377  0,033  Cardiovascular analeptic
0,373  0,032  Antineoplastic (lymphoma)
0,375  0,036  Antineoplastic (multiple myeloma)
0,378  0,039  CYP3A4 inhibitor
0,382  0,055  Immunostimulant
0,331  0,005  Farnesoid X receptor antagonist
0,362  0,041  Antidiabetic (type 2)
0,368  0,053  ICAM1 expression inhibitor
0,312  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,352  0,050  CYP2C19 substrate
0,306  0,022  Prostatic (benign) hyperplasia treatment
0,353  0,071  Antiprotozoal (Plasmodium)
0,284  0,004  Transcription factor NF kappa B stimulant
0,328  0,050  Antineoplastic (cervical cancer)
0,324  0,047  Renal disease treatment
0,296  0,020  Protein-tyrosine phosphatase inhibitor
0,287  0,019  Diabetic nephropathy treatment
0,271  0,003  Arachidonic acid antagonist
0,279  0,012  LDLR expression enhancer
0,264  0,004  CDC25A inhibitor
0,283  0,024  UGT1A3 substrate
0,301  0,043  Antiulcerative
0,279  0,022  Skin whitener
0,303  0,048  Angiogenesis stimulant
0,304  0,051  Free radical scavenger
0,291  0,040  Gastrin inhibitor
0,296  0,045  UGT1A6 substrate
0,285  0,039  UDP-glucuronosyltransferase substrate
0,246  0,005  Inducible nitric-oxide synthase inhibitor
0,301  0,078  Antineoplastic (small cell lung cancer)
0,234  0,012  Alcohol dehydrogenase substrate
0,227  0,006  Pregnane X receptor agonist
0,232  0,011  Choleretic
0,294  0,079  Respiratory analeptic
0,239  0,025  Monophenol monooxygenase inhibitor
0,262  0,049  Antiviral (HIV)
0,274  0,071  UGT1A9 substrate
0,232  0,031  Protein kinase stimulant
0,242  0,043  Neurotrophic factor enhancer
0,224  0,027  Acetylcholinesterase inhibitor
0,253  0,065  Antineoplastic (lymphocytic leukemia)
0,275  0,091  Antimycobacterial
0,231  0,048  P-glycoprotein inhibitor
0,203  0,021  Antineoplastic antibiotic
0,182  0,005  5-Alpha-reductase inhibitor
0,173  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,253  0,089  Antituberculosic
0,185  0,022  Beta amyloid protein antagonist
0,242  0,081  Antineoplastic (non-small cell lung cancer)
0,197  0,039  UGT2B10 substrate
0,162  0,011  Postmenopausal disorders treatment
0,153  0,005  Na+ K+ transporting ATPase inhibitor
0,192  0,044  Melanin inhibitor
0,168  0,023  UGT2B1 substrate
0,217  0,073  Antihypertriglyceridemic
0,186  0,042  Antidiarrheal
0,150  0,006  Anticholelithogenic
0,192  0,050  Cholinergic
0,170  0,028  Butyrylcholinesterase inhibitor
0,146  0,007  CDC25B inhibitor
0,153  0,017  Anabolic
0,245  0,109  Analeptic
0,138  0,003  Farnesoid X receptor agonist
0,186  0,055  Phospholipase C inhibitor
0,155  0,030  Contraceptive female
0,128  0,004  Heme oxygenase stimulant
0,251  0,127  Vasodilator, peripheral
0,135  0,011  Bile acid receptor antagonist
0,221  0,098  Antineoplastic (sarcoma)
0,168  0,047  Bone formation stimulant
0,189  0,068  Antiviral (Hepatitis)
0,173  0,052  Antineoplastic (squamous cell carcinoma)
0,207  0,090  RNA-directed DNA polymerase inhibitor
0,136  0,021  Paget's disease treatment
0,147  0,032  Anticataract
0,147  0,033  TRPA1 agonist
0,132  0,024  ABCA1 expression enhancer
0,145  0,039  Papain-like protease (SARS coronavirus) inhibitor
0,114  0,009  Hypercalcemia treatment
0,121  0,018  Estrogen receptor alpha antagonist
0,149  0,048  Antihemorrhagic
0,148  0,048  Proteasome inhibitor
0,149  0,050  Retinoprotector
0,105  0,008  Aldosterone antagonist
0,126  0,029  UGT2B11 substrate
0,197  0,102  Antiamyloidogenic
0,201  0,107  Antidiabetic symptomatic
0,187  0,097  Embryotoxic
0,091  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,093  0,007  Lipocortins synthesis agonist
0,185  0,102  Teratogen
0,090  0,007  Secretase gamma inhibitor
0,120  0,041  Antiviral (SARS coronavirus)
0,120  0,041  Antiviral (Coronavirus)
0,167  0,092  Antihelmintic
0,132  0,058  Antiviral (Hepatitis B)
0,128  0,058  Autism spectrum disorders treatment
0,073  0,006  Parathyroid hormone antagonist
0,070  0,004  Vitamin D receptor antagonist
0,120  0,055  Estrogen antagonist
0,160  0,096  Sensitization
0,112  0,050  Dementia treatment
0,108  0,049  Vascular dementia treatment
0,091  0,034  Ca(v)3.1 blocker
0,129  0,073  Liver cirrhosis treatment
0,164  0,108  CYP2B6 inhibitor
0,118  0,063  Microtubule formation inhibitor
0,100  0,046  Actinic keratosis treatment
0,218  0,165  CYP3A4 substrate
0,104  0,058  Estrogen receptor beta antagonist
0,123  0,079  Anesthetic
0,050  0,007  HMG CoA reductase inhibitor
0,071  0,029  Androgen agonist
0,134  0,093  Phospholipase A2 inhibitor
0,161  0,120  Antiparasitic
0,128  0,088  UGT2B15 substrate
0,052  0,013  RNA-directed RNA polymerase stimulant
0,065  0,028  Postcoital contraceptive
0,055  0,018  Geranyltranstransferase inhibitor
0,085  0,049  Glycine receptor antagonist
0,098  0,063  Nitric-oxide synthase inhibitor
0,050  0,015  Glucocorticoid antagonist
0,124  0,090  Antieczematic
0,101  0,069  Toll-Like receptor 4 antagonist
0,066  0,036  Antimycoplasmal
0,087  0,059  Ornithine decarboxylase inhibitor
0,058  0,031  Acetyl-CoA transferase inhibitor
0,168  0,142  Myocardial infarction treatment
0,034  0,008  CYP24 inhibitor
0,033  0,008  1,3-Beta-glucan synthase inhibitor
0,033  0,008  5-Alpha-reductase 1 inhibitor
0,027  0,004  Telomerase stimulant
0,204  0,182  Interleukin 2 agonist
0,044  0,026  Alpha 1L adrenoreceptor agonist
0,057  0,039  Pregnane X receptor antagonist
0,116  0,098  Lipid peroxidase inhibitor
0,121  0,104  Mutagenic
0,135  0,119  Sedative
0,041  0,026  Cholesterol absorption inhibitor
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,029  0,014  Retinoid X gamma receptor antagonist
0,039  0,024  Glucose-6-phosphate dehydrogenase inhibitor
0,046  0,033  Microtubule stabilization
0,069  0,056  Glycine receptor agonist
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,069  0,057  Antibiotic
0,019  0,008  Vitamin D receptor agonist
0,077  0,069  Androgen antagonist
0,105  0,100  Antihyperlipoproteinemic
0,017  0,013  Progesterone agonist
0,110  0,105  Antineoplastic (carcinoma)
0,103  0,099  Cyclooxygenase 3 inhibitor
0,019  0,018  Corticosteroid-like
0,004  0,003  Vitamin D-like

